UNSPSC 51102822: Bacitracin/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102822 Bacitracin/polymyxin b is a Commodity code that in recent state and local procurement appears disconnected from the actual work being solicited under it. The recent opportunities tagged to this code involve naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS Commission), medical and first aid supplies for emergency response (City of Tampa), and generic pharmaceuticals through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these procurements center on bacitracin/polymyxin b topical antibiotic ointment or similar narrow-spectrum antibiotic products. The code shows little relevant recent activity aligned with its nominal scope.

The geographic spread of the few tagged opportunities spans Florida, Texas, Minnesota, and Oregon, reflecting state health and human services departments, county health systems, municipal fire departments, and cooperative purchasing alliances as issuing bodies. The mismatch between the code name and the actual pharmaceutical and medical supply work being solicited suggests either miscoding in the source data or that bacitracin/polymyxin b procurement by state and local governments is not currently surfacing in available solicitation notices. A business development professional pursuing this code should verify whether state and local demand for bacitracin/polymyxin b products exists through direct outreach to state health departments, county health systems, and emergency medical services procurement offices rather than relying on tagged opportunities.